Danaher (NYSE:DHR) Posts Quarterly Earnings Results, Beats Expectations By $0.19 EPS

Danaher (NYSE:DHR) issued its earnings results on Tuesday. The conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.19, FiscalAI reports. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion.

Danaher Stock Performance

Shares of DHR opened at $224.78 on Wednesday. The company has a 50-day simple moving average of $214.70 and a 200-day simple moving average of $196.54. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $158.02 billion, a PE ratio of 39.93, a P/E/G ratio of 2.82 and a beta of 0.76. Danaher has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Evercore reissued an “outperform” rating and set a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Royal Bank Of Canada lifted their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. The Goldman Sachs Group boosted their target price on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Morgan Stanley raised their price target on Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday, October 12th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $235.41.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.